BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

675 related articles for article (PubMed ID: 11013390)

  • 21. Karyotype alteration generates the neoplastic phenotypes of SV40-infected human and rodent cells.
    Bloomfield M; Duesberg P
    Mol Cytogenet; 2015; 8():79. PubMed ID: 26500699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How aneuploidy affects metabolic control and causes cancer.
    Rasnick D; Duesberg PH
    Biochem J; 1999 Jun; 340 ( Pt 3)(Pt 3):621-30. PubMed ID: 10359645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular basis of multistage carcinogenesis.
    Harris CC
    Princess Takamatsu Symp; 1991; 22():3-19. PubMed ID: 1844248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic pathways of two types of gastric cancer.
    Tahara E
    IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cell clone ecology hypothesis and the cell fusion model of cancer progression and metastasis: history and experimental support.
    Parris GE
    Med Hypotheses; 2006; 66(1):76-83. PubMed ID: 16169667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TP53 mutation spectra and load: a tool for generating hypotheses on the etiology of cancer.
    Olivier M; Hussain SP; Caron de Fromentel C; Hainaut P; Harris CC
    IARC Sci Publ; 2004; (157):247-70. PubMed ID: 15055300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Destructive cycles: the role of genomic instability and adaptation in carcinogenesis.
    Schneider BL; Kulesz-Martin M
    Carcinogenesis; 2004 Nov; 25(11):2033-44. PubMed ID: 15180945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chromosomal alterations cause the high rates and wide ranges of drug resistance in cancer cells.
    Li R; Hehlman R; Sachs R; Duesberg P
    Cancer Genet Cytogenet; 2005 Nov; 163(1):44-56. PubMed ID: 16271955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spindle assembly checkpoint and centrosome abnormalities in oral cancer.
    Thirthagiri E; Robinson CM; Huntley S; Davies M; Yap LF; Prime SS; Paterson IC
    Cancer Lett; 2007 Dec; 258(2):276-85. PubMed ID: 17959302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aneuploidy and cancer: from correlation to causation.
    Duesberg P; Li R; Fabarius A; Hehlmann R
    Contrib Microbiol; 2006; 13():16-44. PubMed ID: 16627957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Speciation Theory of Carcinogenesis Explains Karyotypic Individuality and Long Latencies of Cancers.
    Hirpara A; Bloomfield M; Duesberg P
    Genes (Basel); 2018 Aug; 9(8):. PubMed ID: 30096943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A stem cell fusion model of carcinogenesis.
    He X; Tsang TC; Pipes BL; Ablin RJ; Harris DT
    J Exp Ther Oncol; 2005; 5(2):101-9. PubMed ID: 16471036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The mitotic checkpoint in cancer and aging: what have mice taught us?
    Baker DJ; Chen J; van Deursen JM
    Curr Opin Cell Biol; 2005 Dec; 17(6):583-9. PubMed ID: 16226453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The dialectics of cancer: A theory of the initiation and development of cancer through errors in RNAi.
    Wynter CV
    Med Hypotheses; 2006; 66(3):612-35. PubMed ID: 16359827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two genetic hits (more or less) to cancer.
    Knudson AG
    Nat Rev Cancer; 2001 Nov; 1(2):157-62. PubMed ID: 11905807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistent increase in chromosome instability in lung cancer: possible indirect involvement of p53 inactivation.
    Haruki N; Harano T; Masuda A; Kiyono T; Takahashi T; Tatematsu Y; Shimizu S; Mitsudomi T; Konishi H; Osada H; Fujii Y; Takahashi T
    Am J Pathol; 2001 Oct; 159(4):1345-52. PubMed ID: 11583962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative genomic hybridization and BUB1B mutation analyses in childhood cancers associated with mosaic variegated aneuploidy syndrome.
    Hanks S; Coleman K; Summersgill B; Messahel B; Williamson D; Pritchard-Jones K; Strefford J; Swansbury J; Plaja A; Shipley J; Rahman N
    Cancer Lett; 2006 Aug; 239(2):234-8. PubMed ID: 16182441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Theory and practice of primary cancer prevention].
    Tompa A
    Magy Onkol; 2007; 51(1):7-21. PubMed ID: 17417671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. hBUB1 defects in leukemia and lymphoma cells.
    Ru HY; Chen RL; Lu WC; Chen JH
    Oncogene; 2002 Jul; 21(30):4673-9. PubMed ID: 12096343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immortality of cancers: a consequence of inherent karyotypic variations and selections for autonomy.
    Duesberg P; McCormack A
    Cell Cycle; 2013 Mar; 12(5):783-802. PubMed ID: 23388461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.